Valuation: Qiagen NV

Market Cap 10.18B 9.27B 8.54B 7.77B 14.58B 943B 15.32B 104B 41.33B 515B 38.2B 37.39B 1,616B P/E 2026 *
23.6x
P/E 2027 * 21x
Enterprise Value 10.89B 9.92B 9.14B 8.31B 15.6B 1,008B 16.39B 111B 44.21B 551B 40.86B 40B 1,729B EV / Sales 2026 *
5.1x
EV / Sales 2027 * 4.63x
Free-Float
99.37%
Yield 2026 *
0.13%
Yield 2027 * 0.32%
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2026
Director of Finance/CFO 58 01/01/2004
Chief Operating Officer - 01/04/2022
Director TitleAgeSince
Director/Board Member 77 01/06/2011
Director/Board Member 60 08/01/2021
Director/Board Member 72 23/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%-4.05% - - 10.18B
-2.49%-3.76%+53.38%+62.10% 63.66B
-0.63%-2.91%+6.55%+89.34% 58.56B
-2.37%-2.22%+21.77%+84.58% 54.19B
-2.19%-6.15%+12.43%+111.40% 44.66B
-1.89%-7.28%+9.30%+18.50% 40.51B
-0.93%-0.47%+19.34%+41.83% 36.27B
+1.11%-6.44%+127.46%+675.37% 34.89B
-0.80%+0.61%+76.27%+61.80% 32.26B
-2.17%+16.65%-28.89%+479.93% 31.01B
Average -1.46%-1.22%+33.07%+180.54% 44B
Weighted average by Cap. -1.50%-1.85%+31.83%+155.17%

Financials

2026 *2027 *
Net sales 2.14B 1.95B 1.79B 1.63B 3.06B 198B 3.22B 21.82B 8.67B 108B 8.02B 7.85B 339B 2.25B 2.05B 1.88B 1.71B 3.22B 208B 3.38B 22.94B 9.12B 114B 8.43B 8.25B 356B
Net income 446M 406M 374M 340M 639M 41.29B 671M 4.55B 1.81B 22.55B 1.67B 1.64B 70.78B 499M 455M 419M 381M 715M 46.25B 752M 5.1B 2.03B 25.26B 1.87B 1.83B 79.28B
Net Debt 710M 646M 596M 542M 1.02B 65.71B 1.07B 7.25B 2.88B 35.89B 2.66B 2.61B 113B 210M 191M 176M 160M 300M 19.42B 316M 2.14B 851M 10.61B 787M 770M 33.29B
Logo Qiagen NV
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2025, the group developed more than 500 core consumable products and automated solutions through its over 35 locations worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (34.1%), the United States (47.8%), Americas (4.2%) and other (13.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Qiagen NV